Skip to main content

UBS Group AG

Position in GTBP — GT Biopharma, Inc.

CIK 1610520 ZURICH, V8

Position in GTBP

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$18,754
+$18,753 QoQ
Shares Held
45,970
+4596900.0% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $7,583,514,316 across 563 Biotechnology names. GTBP ranks #422 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GTBP

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,754 45,970
2025-12-31 $1 1
2025-09-30 $1,541 2,626
2025-06-30 $20,799 5,810
2025-03-31 $5,501 2,559
2024-12-31 $15,237 4,996
2024-09-30 $9,012 3,903
2024-06-30 $25,415 8,981
2024-03-31 $4,531 1,023
2023-12-31 14,605
2023-09-30 8,750
2023-06-30 3,033
2023-03-31 7,793
2022-12-31 3,523
2022-09-30 3,170
2022-06-30 3,116
2022-03-31 4,401
2021-12-31 11,444
2021-09-30 4,758
2021-06-30 3,103
2021-03-31 3,918